Mutations in the RAS Signaling, B-Cell Development, TP53/RB1, and JAK Signaling Pathways Are Common in High Risk B-Precursor Childhood Acute Lymphoblastic Leukemia (ALL): A Report From the Children's Oncology Group (COG) High-Risk (HR) ALL TARGET Project.
Year: 2009
Type: article
Source: Blood
Authors: Jinghui Zhang, Charles G. Mullighan, Richard C. Harvey, Kenneth E Buetow, William L. Carroll, I-Ming Chen, Meenakshi Devidas, Michael Edmonson, Daniela Gerhard, Ying Hu, Mignon L. Loh, Letha A Phillips, Gregory H Reaman, Mary V. Relling, Malcolm Smith, James R. Downing, Cheryl L. Willman, Stephen P Hunger
Institutions: National Institutes of Health, National Cancer Institute, St. Jude Children's Research Hospital, University of New Mexico, New York University, UNM Comprehensive Cancer Center, University of Florida Health, University of Florida, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, George Washington University, University of Colorado Anschutz
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2979810523